2024

1. An atlas of cells in the human tonsil

   Immunity, Vol. 57, Núm. 2, pp. 379-399.e18

2. Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma

   Haematologica

3. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

   Clinical Cancer Research, Vol. 30, Núm. 10, pp. 2085-2096

4. Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases

   Biomimetics, Vol. 9, Núm. 1

5. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology

   Journal of Thrombosis and Haemostasis

6. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C

   Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

7. Epigenetic-based differentiation therapy for Acute Myeloid Leukemia

   Nature Communications, Vol. 15, Núm. 1

8. Experimentally-guided in silico design of engineered heart tissues to improve cardiac electrical function after myocardial infarction

   Computers in Biology and Medicine, Vol. 171

9. Fibroblast Diversity and Epigenetic Regulation in Cardiac Fibrosis

   International Journal of Molecular Sciences, Vol. 25, Núm. 11

10. Generation of Self-Induced Myocardial Ischemia in Large-Sized Cardiac Spheroids without Alteration of Environmental Conditions Recreates Fibrotic Remodeling and Tissue Stiffening Revealed by Constriction Assays

    ACS Biomaterials Science and Engineering, Vol. 10, Núm. 2, pp. 987-997

11. HDACi vorinostat protects muscle from degeneration after acute rotator cuff injury in mice

    Bone and Joint Research, Vol. 12, Núm. 4, pp. 169-183

12. Hypocortisolemic ASIA: a vaccine- and chronic infection-induced syndrome behind the origin of long COVID and myalgic encephalomyelitis

    Frontiers in Immunology, Vol. 15

13. Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19

    Blood Cancer Journal, Vol. 14, Núm. 1

14. Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma

    Blood Advances

15. Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

    Cell Death Discovery, Vol. 10, Núm. 1

16. Natural Hydrogels Support Kidney Organoid Generation and Promote In Vitro Angiogenesis

    Advanced Materials, Vol. 36, Núm. 34

17. Novel biomarkers and psoriasis associated cardiovascular risk

    Archives of Dermatological Research, Vol. 316, Núm. 5

18. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

19. Predictors of unsustained measurable residual disease negativity in transplant-eligible patients with multiple myeloma

    Blood, Vol. 143, Núm. 7, pp. 597-603

20. Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma

    American Journal of Hematology